就职 发表于 2025-3-26 23:49:01
Md Akbar,Hasan Ali,Shweta Srivastav,Kainat Alam,Shipra Daniel,Faraat Ali寻找 发表于 2025-3-27 01:54:48
http://reply.papertrans.cn/43/4284/428312/428312_32.png苦笑 发表于 2025-3-27 06:11:45
http://reply.papertrans.cn/43/4284/428312/428312_33.png高原 发表于 2025-3-27 12:20:10
Conventional to Nanoscale-Based Carrier Systems in the Management of Ovarian Cancer,ability, and prolonged therapeutic regimen. Thus, to overcome these limitations nanotherapeutic approaches can be used for the effective delivery of drugs with superior targetability and negligible or no toxicity. In this chapter, we have discussed the major molecular pathways and cellular targets cenormous 发表于 2025-3-27 15:05:34
http://reply.papertrans.cn/43/4284/428312/428312_35.png值得尊敬 发表于 2025-3-27 18:29:52
http://reply.papertrans.cn/43/4284/428312/428312_36.pngadumbrate 发表于 2025-3-27 22:32:45
http://reply.papertrans.cn/43/4284/428312/428312_37.png高度 发表于 2025-3-28 05:59:51
http://reply.papertrans.cn/43/4284/428312/428312_38.png抱负 发表于 2025-3-28 06:46:41
Neuroendocrine Carcinoma of Endometrium Convention Treatment Approach to Nanomedicine,e female genital tract are aggressive and rare tumours that usually involve the cervix and ovary, and are seen rarely in the endometrium in perimenopausal or postmenopausal women But, their prospective role in gNECs still remains uncertain because of the small prevalence. Few subjective proofs existMitigate 发表于 2025-3-28 12:20:24
http://reply.papertrans.cn/43/4284/428312/428312_40.png